doi: 10.3389/fendo.2025.1711016 Received 23 September 2025 Revised 16 December 2025 Accepted 31 December 2025 Published 27 February 2026 Volume 16 - 2025 Edited by Antonio Simone Lagan, University of Palermo, Italy Reviewed by Hui Li, First Peoples Hospital of Changzhou, China Filipa Cristina Costa Ferreira, Instituto Nacional de Pesquisa Agropecuria e Veterinria (INIAV), Portugal Updates Copyright 2026 Xie, Zhang, Lin, Cheng and Huang
ACE2 is a peptidase metabolizes vasoconstrictor angiotensin II (Ang II) to the vasodilator Ang1-7 and Ang1-9 (Al-kuraishy et al
In the following days, daily maintenance doses are usually in the range of 50 mg/kg
For some patients, semaglutide works well and causes minimal side effects
Lower medication costs mean covering more patients becomes financially feasible
Copyright The Nations Health, American Public Health Association